✦ LIBER ✦

AN ANALYSIS OF PATIENT OUT-OF-POCKET SPENDING FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION

✍ Scribed by Armstrong, Shannon; Amorosi, Stacey L.; Patel, Parashar; Erickson, Gavin C.; Stein, Kenneth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of dabigatran for st

✍ Silva Miguel, Luís; Rocha, Evangelista; Ferreira, Jorge 📂 Article 📅 2013 🏛 Elsevier ⚖ 703 KB

Budget Impact Analysis of Rivaroxaban in

✍ Capri, S.; Veneziano, M.; Ricciardi, W.G.; D’Ausilio, A.; Pedone, M.P; Bianchi, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Cost-effectiveness of Dabigatran for Str

✍ González-Juanatey, José R.; Álvarez-Sabin, José; Lobos, José M.; Martínez-Rubio, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Cost-Effectiveness Analysis of Apixaban

✍ Betegón Nicolás, L.; Escolar Albaladejo, G.; Canal Fontcuberta, C.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Effectiveness Analysis of Apixaban

✍ Canal Fontcuberta, C.; Escolar Albaladejo, G.; Betegón Nicolás, L.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Stroke Prevention in Non-Valvular Atrial

✍ Costa, S.; Ramos, J.C.; Braga, A.C.; Pereira, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB